PEGS Europe
Network with 1,500+ colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as “the best biologics technology meeting in Europe.” New this year is expanded coverage of AI/ML, multispecific antibodies, antibody-drug conjugates, and an entire stream devoted to Oncology.
Date: November 5-7, 2024
Location: Barcelona, Spain
Booth: #1002
JOIN US!
We are excited to meet you in Barcelona for #PEGS Europe! Visit our booth 1002# Catalent Biologics can accelerate your cell line & process development and drug substance manufacturing programs from the clinical phase to commercial scale.
Complete the form to schedule a meeting with Catalent experts at PEGS Europe!
POSTER PRESENTATION
Title: Poster Presentation: GPEx® Lightning: Digital Control of Expression for Rapid, High-Titer Production of Complex Products in CHO Cells
Date: November 5-7, 2024
Speaker: Laura Daley, Ph.D. Senior Director, Molecular & Cellular Biology, Catalent Biologics
PRESENTER
Laura Daley, Ph.D
Senior Director, Molecular & Cellular Biology
Catalent Biologics
ABOUT CATALENT BIOLOGICS
For nearly three decades, Catalent Biologics has built capabilities and expertise in development, manufacturing, and analytical services, now spanning new biological entities, biosimilars, plasmid DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. It has developed 600+ antibodies and 80+ recombinant proteins, with more than 120 active clinical trials and 16 marketed biotherapeutics use GPEx® cell line engineering technology. More than 45 commercially approved products have employed Catalent Biologics’ manufacturing and packaging capabilities.
Using advanced technologies and tailored solutions from clinical to commercial supply, Catalent brings better biologic and advanced treatments to patients, faster.
